论文部分内容阅读
腹膜后软组织肉瘤(RPS)复发或转移后的治疗非常棘手,对于无法获得根治性切除病人的姑息治疗尚有许多问题需要探讨。大多数RPS病人在他们疾病的进展过程中都将面临选择姑息治疗,手术、放疗和化疗是最常用的姑息治疗手段。一些病人通过合理的治疗后获得症状的缓解或生活质量的改善。当复发或转移的RPS选择进行姑息手术或放化疗时,应充分评估治疗的意义,平衡治疗获益及毒性反应。治疗肿瘤相关的疼痛、贫血、恶液质和短肠综合征同样具有重要的意义。
Retroperitoneal soft tissue sarcoma (RPS) after the recurrence or metastasis of the treatment is very tricky, for patients who can not get radical resection of palliative treatment there are still many issues to be explored. Most RPS patients will face the palliative treatment of choice as their disease progresses, surgery, radiation and chemotherapy are the most commonly used palliative treatments. Some patients get symptomatic relief or improvement of quality of life after reasonable treatment. When recurrent or metastatic RPS is chosen for palliative or chemoradiation, the significance of the treatment should be fully assessed to balance the benefit of treatment and toxicity. Treating tumor-associated pain, anemia, cachexia and short bowel syndrome is equally important.